Potential of HILIC‐MS in quantitative bioanalysis of drugs and drug metabolites
- 23 May 2008
- journal article
- review article
- Published by Wiley in Journal of Separation Science
- Vol. 31 (9) , 1481-1491
Abstract
One fundamental requirement for many lead optimization processes is the need for bioanalytical support within pharmaceutical drug discovery and development. Currently, most bioanalytical methods for pharmaceutical analysis employ HPLC coupled with MS/MS. The combination of HPLC and MS/MS detection frequently offers the complete resolution of the dosed compounds from their metabolites and the endogenous interferences to avoid extra efforts for chemical separation and sample clean‐up procedures resulting in higher‐throughput assays for a series of new chemical entities (NCEs). Hydrophilic interaction chromatography (HILIC) has been demonstrated to be a powerful technique for the retention of polar analytes offering a difference in selectivity compared to traditional RP chromatography. This review summarizes the HILIC‐MS/MS methods for the trace quantitative determinations of the drug compounds and their metabolites to support both in vitro and in vivo experiments. The challenges on performing HILIC‐MS/MS assays such as matrix ionization suppression and the potential for endogenous interferences are also presented.Keywords
This publication has 84 references indexed in Scilit:
- Analysis of [3′,3′-d2]-nicotine and [3′,3′-d2]-cotinine by capillary liquid chromatography–electrospray tandem mass spectrometryJournal of Chromatography B, 2007
- Comparison of fast liquid chromatography/tandem mass spectrometric methods for simultaneous determination of cladribine and clofarabine in mouse plasmaJournal of Pharmaceutical and Biomedical Analysis, 2007
- Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analysesJournal of Chromatography B, 2007
- Analysis of carvedilol in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2007
- A 96-well single-pot liquid–liquid extraction, hydrophilic interaction liquid chromatography–mass spectrometry method for the determination of muraglitazar in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2006
- Hydrophilic interaction liquid chromatography–tandem mass spectrometry for the determination of levofloxacin in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2006
- Evaluation of volatile ion-pair reagents for the liquid chromatography–mass spectrometry analysis of polar compounds and its application to the determination of methadone in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2006
- Hydrophilic interaction liquid chromatography–APCI–mass spectrometry determination of 5-fluorouracil in plasma and tissuesJournal of Pharmaceutical and Biomedical Analysis, 2005
- Simultaneous development of six LC–MS–MS methods for the determination of multiple analytes in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2002
- DEVELOPMENT AND VALIDATION OF A LIQUID CHROMATOGRAPHY–TANDEM MASS SPECTROMETRY METHOD, USING SILICA COLUMN AND AQUEOUS-ORGANIC MOBILE PHASE, FOR THE ANALYSIS OF CLONIDINE AS LOW AS 10 pg/mL IN HUMAN SERUMJournal of Liquid Chromatography & Related Technologies, 2002